Keyphrases
Therapeutic Implications
100%
Signaling Mechanism
100%
Pancreatic Cancer
100%
Sirtuins
100%
Pancreatic Ductal Adenocarcinoma
50%
Chemoresistance
33%
NAD+-dependent
33%
Sirtuin 6 (SIRT6)
33%
Apoptosis
16%
Patient Outcomes
16%
Metastasis
16%
Therapeutic Intervention
16%
Rapid Progression
16%
Gemcitabine
16%
Cellular Processes
16%
Angiogenesis
16%
Glycolysis
16%
Tumor Invasiveness
16%
Tumorigenesis
16%
Therapeutic Efficacy
16%
Hypoxia
16%
Complex Networks
16%
Sirtuin 1 (SIRT1)
16%
Metabolic Reprogramming
16%
Aerobic Glycolysis
16%
Sirtuin 3 (SIRT3)
16%
Genome Integrity
16%
Epigenetic Dysregulation
16%
Targeted Therapeutics
16%
Glutamine Metabolism
16%
Tumor Survival
16%
Tumor Suppression
16%
Cancer Cell Proliferation
16%
Glycolytic Metabolism
16%
Metabolic Dependencies
16%
Mitochondrial Reactive Oxygen Species (mtROS)
16%
Comprehensive Exploration
16%
Deacetylases
16%
Sirtuin 5 (SIRT5)
16%
Glutathione Metabolism
16%
Pancreatic Cancer Progression
16%
SIRT2
16%
Curb
16%
Genetic Dysregulations
16%
Lethal Cancer
16%
Eukaryotic Translation Initiation Factor 5A (eIF5A)
16%
Pancreatic Malignancy
16%
SIRT7
16%
Epigenetic Modulation
16%
HIF-1 Signaling Pathway
16%
SIRT4
16%
Challenging Contexts
16%
Biochemistry, Genetics and Molecular Biology
Signaling Mechanism
100%
Sirtuin
100%
Epigenetics
33%
Drug Resistance
33%
SIRT6
33%
Upregulation
16%
Reprogramming
16%
Enzyme
16%
Genetics
16%
Cancer Cell
16%
Glutamine
16%
Carcinogenesis
16%
Metabolic Pathway
16%
Angiogenesis
16%
Cell Proliferation
16%
Sirtuin1
16%
Aerobic Glycolysis
16%
SIRT2
16%
Glutathione Metabolism
16%
SIRT3
16%
SIRT7
16%
SIRT4
16%
SIRT5
16%
Genomics
16%
Gemcitabine
16%
Programmed Cell Death
16%
Pharmacology, Toxicology and Pharmaceutical Science